Propafenone HCL 225 mg tablets Recalled
Source: The Food and Drug Administration
The FDA and Watson Pharmaceuticals are recalling Propafenone HCL 225 mg tablets, 100-count bottles. This drug is used to treat an irregular heartbeat.
Propafenone HCL 225 mg tablets are being recalled because some tablets may have slightly higher levels of the active ingredient than specified. Patients who are sensitive to small variations in dose may face potentially serious side effects, including an irregular heartbeat or low blood pressure.
The affected lot [lot number 112680A, expiration date July 31, 2010] of Propafenone HCL tablets was shipped to customers between October 15, 2008 and November 26, 2008. The Press Release includes instructions for identifying and returning the affected product.
Read the MedWatch safety summary, including a link to the company Press Release.
|
